Market Cap

Bio-Path Holdings, Inc. Market Capitalization:

$6.8 Million

USD as of Jan. 1, 2024

business Bio-Path Holdings, Inc. Company Profile

Bio-Path Holdings, Inc. Main Stock Listing

NASDAQ: BPTH

Market Capitalization History of Bio-Path Holdings, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Bio-Path Holdings, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $6.8 M -54.27%
Jan. 1, 2023 $15.0 M -44.12%
Jan. 1, 2022 $26.8 M -17.87%
Jan. 1, 2021 $32.6 M -34.60%
Jan. 1, 2020 $49.9 M 198.58%
Jan. 1, 2019 $16.7 M -94.95%
Jan. 1, 2018 $330.8 M -77.89%
Jan. 1, 2017 $1.50 B -32.14%
Jan. 1, 2016 $2.21 B -38.05%
Jan. 1, 2015 $3.56 B -48.75%
Jan. 1, 2014 $6.95 B 1278.13%
Jan. 1, 2013 $504.1 M 28.00%
Jan. 1, 2012 $393.8 M -39.02%
Jan. 1, 2011 $645.9 M 17.14%
Jan. 1, 2010 $551.3 M -46.15%
Jan. 1, 2009 $1.02 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Bio-Path Holdings, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Bio-Path Holdings, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BPTH

Stock: FSX: IBPB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.